Oramed Granted U.S. Combination Therapy Patent for Oral GLP-1 & Insulin for the Treatment of Diabetes January 4, 2023 Press Releases
Oramed Announces Publication of Oral Insulin Study in Peer-Reviewed Journal: Diabetes, Obesity, and Metabolism November 29, 2022 Press Releases
Oramed Announces Additional Positive Safety and Efficacy Data from Its Phase 2 Clinical Trial of ORMD-0801 for NASH November 17, 2022 Press Releases
Oramed Signs Definitive Deal with Medicox to Commercialize Oral Insulin in South Korea November 14, 2022 Press Releases
Oramed to Host Webinar Highlighting Detailed Safety and Efficacy Data from Its Positive Phase 2 Clinical Trial of ORMD-0801 for NASH November 9, 2022 Press Releases
Oramed Subsidiary Oravax Reports Positive Preliminary Phase 1 Data for its Oral Covid-19 Vaccine October 7, 2022 Press Releases
Oramed Reports Positive Top-Line Results from Phase 2 NASH Trial with its ORMD-0801, Oral Insulin Candidate September 13, 2022 Press Releases
Oramed to Present at H.C. Wainwright 24th Annual Global Investment Conference September 6, 2022 Press Releases
